Impacts of hepatitis B and hepatitis C co-infection with tuberculosis, a prospective cohort study
Open Access
- 23 July 2020
- journal article
- research article
- Published by Springer Nature in Virology Journal
- Vol. 17 (1) , 1-8
Abstract
Background: This study was conducted to estimate the prevalence, determinants of hepatitis B, hepatitis C and the survival of tuberculosis patients until drug-induced hepatitis.Methods: Prospective cohort study design was implemented. The data were collected from September 2016 – May 2019. Systematic random sampling was used to select the study participants. Baseline data were collected before the patient starts DOTS, the sign of liver toxicity was assessed every week. Tuberculosis treatment outcomes and WHO clinical stage was recorded at the end of 6th months. Descriptive statistics were used to estimate the prevalence of hepatitis B, hepatitis C viral infections and their effect on tuberculosis treatment outcomes. Binary logistic regression was used to identify the determinants of hepatitis B and C infections. The Kaplan Meier survival curve was used to estimate the survival of tuberculosis patient and Cox regression was used to identify the predictors of drug-induced hepatitis.Results: A total of 3537 tuberculosis patients were followed. The prevalence of hepatitis B and C viral infection among tuberculosis patients were 15.1 and 17.3% respectively. Hepatitis B viral infection among tuberculosis patients was associated with alcohol, sex, HIV, chronic illness. Hepatitis C viral infection among tuberculosis patients was associated with alcohol, sex, HIV, chronic illness. The incidence density for liver toxicity among tuberculosis patients was 843/15707 person-months and liver toxicity was determined by HIV, Hepatitis B, Hepatitis C, the severity of tuberculosis and chronic illnesses.Conclusion: Decision-makers should consider incorporating screening for hepatitis B and C viral infection during tuberculosis treatment.Keywords
This publication has 50 references indexed in Scilit:
- Gender disparity in chronic hepatitisB: Mechanisms of sex hormonesJournal of Gastroenterology and Hepatology, 2015
- A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in TaiwanKidney International, 2015
- Hepatitis B virus infectionThe Lancet, 2014
- Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virusInternational Journal of Infectious Diseases, 2014
- Daily Associations Between Alcohol Use and Unprotected Anal Sex Among Heavy Drinking HIV-Positive Men Who Have Sex with MenAIDS and Behavior, 2014
- Hepatitis C Virus Co-Infection Increases the Risk of Anti-Tuberculosis Drug-Induced Hepatotoxicity among Patients with Pulmonary TuberculosisPLOS ONE, 2013
- Prevalence of hepatitis B virus infection among tuberculosis patients with or without HIV in Goiânia City, BrazilJournal of Clinical Virology, 2012
- Hepatitis B: Epidemiology and prevention in developing countriesWorld Journal of Hepatology, 2012
- Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis BAIDS, 2007
- Genomic analysis of the host response to hepatitis B virus infectionProceedings of the National Academy of Sciences, 2004